Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
XtRNA Bio, born from Radboud University, seeks a Scientist to drive translational R&D in RNA biology and neuromuscular gene therapy. The lab-based role is on the Radboud University campus in Nijmegen, designing, executing, and interpreting experiments to optimize AAV-tRNA platforms for neuromuscular disease applications with in vivo and in vitro models.
You will work closely with a research associate and report to the scientific director to advance the platform, contribute to data analyses, and
Radboud University, Nijmegen, the Netherlands
February 2027
€50,000 to €55,000 gross per year
1-year contract with renewal possibility
XtRNA Bio is a spin-out from Radboud University, co-founded by Professor Erik Storkebaum and NLC Health Ventures. We aim to deliver disease-modifying treatments that promise to significantly improve the quality of life for patients with severe, unmet medical needs. We are pioneering tRNA-based therapies to correct the root cause of protein translational defects by elevating tRNA pools or expressing suppressor tRNAs . Our team unites expertise in tRNA biology, gene therapy, neuromuscular pathophysiology, and translational therapeutics.
We are looking for a forward-thinking scientist to serve as a key driver of our translational R&D efforts. The position is lab-based on the campus of Radboud University in Nijmegen and involves designing, executing, and interpreting experiments that optimize our AAV-tRNA platforms for neuromuscular disease applications, including studies in relevant animal and in vitro models . The successful candidate will work closely with a research associate and have the support of the scientific director to advance our tRNA elevation platform.
XtRNA Bio offers a unique opportunity to pioneer the emerging field of tRNA therapeutics for neuromuscular diseases. By joining early, you can directly influence both the scientific trajectory of our programs and the strategic growth of the company. Our dynamic and collaborative culture emphasizes innovation, personal development, and a shared commitment to delivering life-changing therapies for patients.